IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1438
Positioning
Market Dominance
Manufacturing
Chemicals
$1.9B
Patrick S. Williams
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals. Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. Performance Chemicals segment provides technology-based solutions for its customers' processes or products. Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = IOSP ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$IOSP INNOSPEC INC. | 54 | 54 | 54 | 36 | 19.6x | 15.7x | 7.7% | 5.6% | 27.7% | 7.3% | 5.8% | 1.6% | 2.1% | 37.0x | $1.9B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
INNOSPEC INC. (IOSP) receives a "Hold" rating with a composite score of 53.7/100. It ranks #1438 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Patrick S. Williams
Chief Executive Officer
Labor Force
2,100
54
39
85
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for IOSP
Lagging peers — losers tend to keep underperforming
Fair valuation relative to peers
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for IOSP.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 54 | 42 | +12ALPHA |
| MOMENTUM | 36 | 16 | +20ALPHA |
| VALUATION | 54 | 33 | +21ALPHA |
| INVESTMENT | 39 | 70 | -31DRAG |
| STABILITY | 85 | 88 | -3NEUTRAL |
| SHORT INT | 74 | 84 | -10DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 7.7% (sector -2.5%)
GM 28% vs sector 43%, OM 7% vs sector 1%
Capital turnover N/A, R&D intensity 2.9%
Rev growth 2%, 10yr history
Interest coverage N/A, Net debt/EBITDA -2.1x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns INNOSPEC INC. a Hold rating, with a composite score of 53.7/100 and 3 out of 5 stars. Ranked #1438 of 7,333 stocks, IOSP presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 54/100, IOSP shows adequate but unremarkable business quality. The company reports a return on equity of 7.7% (sector avg: -2.5%), gross margins of 27.7% (sector avg: 42.5%), net margins of 5.8% (sector avg: -0.2%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
IOSP's value score of 54/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 19.61x, an EV/EBITDA of 15.69x, a P/B ratio of 1.51x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
INNOSPEC INC.'s investment score of 39/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 1.6% vs. a sector average of 5.9% and a return on assets of 5.6% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
IOSP is currently showing below-average momentum at 36/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 1.6% year-over-year, while a beta of 0.74 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
INNOSPEC INC. earns an excellent stability score of 85/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.74 and a debt-to-equity ratio of 37.00x (sector avg: 0.2x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
IOSP carries a short interest score of 74/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 37.00x), small-cap liquidity risk. At $1.9B market cap (small-cap), INNOSPEC INC. offers reasonable institutional liquidity.
IOSP pays a solid dividend yield of 2.1%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
INNOSPEC INC. is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1438 of 7,333 overall (80th percentile). Key comparisons include ROE of 7.7% exceeding the -2.5% sector median and operating margins of 7.3% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While IOSP currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Stability (85) vs Momentum (36) — closing this gap could shift the rating.
EV/EBITDA 37% ABOVE SECTOR MEDIAN
ROE 410% BELOW SECTOR MEDIAN
Gross Margin 35% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate INNOSPEC INC. (IOSP) as a Hold with a composite score of 53.7/100 at a current price of $79.29. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (85th percentile) and quality (54th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (36th percentile) and investment (39th percentile) tempers our overall conviction. We assign a No Moat rating (34/100), Low uncertainty, and Standard capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
INNOSPEC INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 53.7/100 places it at rank #1438 in our full 7,333-stock universe. At $1.9B in market capitalization, INNOSPEC INC. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 2%, though momentum at the 36th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 28% (-14.8pp vs sector) narrow to operating margins of 7% (+6.0pp vs sector) and net margins of 5.8%, yielding a gross-to-net conversion rate of 21%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $79.29, INNOSPEC INC. is trading near fair value based on current fundamentals. Our value factor score of 54/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 19.6x (roughly in line with the sector median of 22.3x), EV/EBITDA of 15.7x (at a premium), P/B of 1.5x, P/S of 1.1x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
A 2.11% dividend yield provides income while you wait, and dividends historically account for a significant portion of total equity returns.
Elevated short interest (74th percentile) indicates that sophisticated market participants are betting against the stock.
We assign a Low uncertainty rating to INNOSPEC INC.. The company exhibits strong financial stability with a beta of 0.74, conservative leverage (37% D/E), and a stability factor in the 85th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
We identify no major risk factors at this time. The company's stability factor sits at the 85th percentile with quality at the 54th percentile, both of which support our low-risk assessment. The absence of material leverage, profitability, or volatility concerns reduces the likelihood of a permanent capital loss scenario.
Key risk mitigants include: above-average stability (85th percentile) suggests predictable business dynamics; a 2.11% dividend yield anchors total return. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate INNOSPEC INC.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 7.7%, and the balance sheet is managed within acceptable parameters (D/E: 37%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; INNOSPEC INC. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. The 2.11% dividend yield provides some income return, but the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, INNOSPEC INC. receives a Hold rating with a composite score of 53.7/100 (rank #1438 of 7,333). Our quantitative framework assigns a No Moat (34/100, trend: stable), Low uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 53/100.
Our analysis supports a neutral stance on INNOSPEC INC.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign INNOSPEC INC. a meaningful economic moat, scoring 34/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 11.6/20.
The strongest moat sources are margin superiority (11.6/20) and financial resilience (9.5/20). GM 28% vs sector 43%, OM 7% vs sector 1%. Interest coverage N/A, Net debt/EBITDA -2.1x. These pillars form the core of INNOSPEC INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (1/20) and economic value creation (5.4/20). Capital turnover N/A, R&D intensity 2.9%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect INNOSPEC INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers are not clearly identifiable from current fundamentals. This may reflect a company in transition, a cyclical downturn, or structural challenges in the business model. We assign a quality factor of 54/100 which provides some comfort regarding earnings sustainability.
The margin profile shows gross margins of 28%, operating margins of 7%, net margins of 5.8%. Return metrics include ROE of 7.7% and ROA of 5.6%. Relative to the Manufacturing sector, gross margins are 14.8 percentage points below the sector median of 43%, and ROE of 7.7% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 37%, a dividend yield of 2.11%, revenue growth of 2%. The sector median D/E is 0%, putting INNOSPEC INC. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
The global silicone market, valued at approximately USD 18.18 billion in 2025, is projected to grow at a 5.15% CAGR, reaching around USD 27.16 billion by 2033. This versatile synthetic polymer, known for exceptional stability, flexibility, and resistance, is essential in industries like construction, automotive, and healthcare. Increasing demand for silicone-based solutions, driven by urbanization and renewable energy advancements, boosts market growth. Key players like Illinois Tool Works Inc.,

Innospec (IOSP) reported mixed Q4 2025 results, beating earnings estimates but missing on revenue. The company highlighted strong cash flow and improving margins in key segments for 2026.
Innospec (NASDAQ:IOSP) reported quarterly earnings of $1.50 per share which beat the analyst consensus estimate of $1.24 by 20.97 percent. This is a 6.38 percent increase over earnings of $1.41 per share from the same
Operator: Good day, and thank you for standing by. Welcome to the Innospec Inc. Fourth Quarter 2025 Earnings Release Conference Call and Webcast.
Innospec (NASDAQ:IOSP) executives highlighted operating income growth in Fuel Specialties and improving results in Performance Chemicals and Oilfield Services during the company’s fourth-quarter 2025 earnings call, while also flagging a significant first-quarter 2026 impact from a late-January winte